There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
Aminomalonamide-13C3 is an intermediate in the synthesis of Favipiravir-13C3 (F103352), which is the isotope labelled analog of Favipiravir. Favipiravir is used for the treatment of advanced Ebola virus infection in a small animal model. Favipiravir suppressed the replication of Zaire Ebola virus and prevented a lethal outcome in 100% of the animals. Based on the studies, Favipiravir can be a candidate for the treatment of Ebola hemorrhagic fever. It is a COVID19-related research product.
Hazard Compound
Refer MSDS for complete information.
Overview
Aminomalonamide-13C3 is an intermediate in the synthesis of Favipiravir-13C3 (F103352), which is the isotope labelled analog of Favipiravir. Favipiravir is used for the treatment of advanced Ebola virus infection in a small animal model. Favipiravir suppressed the replication of Zaire Ebola virus and prevented a lethal outcome in 100% of the animals. Based on the studies, Favipiravir can be a candidate for the treatment of Ebola hemorrhagic fever. It is a COVID19-related research product.
![tert-butyl 3-(2-chloro-7-(8-ethyl-7-fluoro-3-(methoxymethoxy)naphthalen-1-yl)-6,8-difluoroquinazolin-4-yl)-3,8-diazabicyclo[3.2.1]octane-8-carboxylate](https://structures.clearsynth.com/CS-O-50224.PNG)
![Cis-Hexahydropyrrolo[3,4-b]pyrrol-6(6aH)-one (rel)](https://structures.clearsynth.com/CS-O-61861.PNG)
